Access to this article is restricted until 12 months after publication by request of the publisher. Restriction lift date: 2025-06-27
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
Loading...
Files
Date
2024-06-27T00:00:00Z
Authors
Pappa, Christina
Galaal, Khadra
Smyth, Sarah
Bristow, Robert E.
Khashan, Ali S.
Alazzam, Mo'iad
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley & Sons, Inc.
Published Version
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.
Description
Keywords
Cytoreductive surgery plus chemotherapy , Chemotherapy alone , Recurrent epithelial ovarian cancer
Citation
Pappa, C., Galaal, K., Smyth, S., Bristow, R. E., Khashan, A. S. and Alazzam, M. (2024) 'Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer', Cochrane Database of Systematic Reviews 2024, Issue 6, CD015297 (15pp). https://doi.org/10.1002/14651858.CD015297 (Accessed: 11 July 2024)
Link to publisher’s version
Collections
Copyright
© 2024, The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.